Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 43 Show results per page	View Search Criteria \| Help With Results

Last Modified: 2/3/2003 First Published: 11/1/2000


1.		Phase I/II Study of Docetaxel and Flavopiridol in Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NCI-00-C-0212 NCI-952, 952, NCT00020332

Last Modified: 9/1/1999


2.		Phase II Study of Protein Kinase C Inhibitor Flavopiridol in Patients With Advanced Gastric Carcinoma (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-97050 NCI-T96-0111, T96-0111

Last Modified: 4/1/2000


3.		Phase II Study of Flavopiridol for Recurrent Intermediate and High Grade Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8548 NCI-T96-0099, NCT00003039, T96-0099

Last Modified: 11/1/1999


4.		Phase II Study of Flavopiridol for Multiple Myeloma That Has Failed One Prior Chemotherapy Regimen (Summary Last Modified 11/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8551 NCI-T96-0095, T96-0095

Last Modified: 4/1/2001 First Published: 12/1/1997


5.		Phase II Study of Flavopiridol in Patients With Metastatic Renal Cell Carcinoma (Summary Last Modified 04/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UCCRC-8552 NCI-T96-0093, T96-0093

Last Modified: 3/1/2000 First Published: 3/1/1998


6.		Phase II Study of Flavopiridol in Patients with Relapsed or Refractory Mantle Cell Lymphoma (Summary Last Modified 03/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Over 18				NCI				DFCI-97129 NCI-T97-0039, T97-0039

Last Modified: 1/1/2000 First Published: 4/1/1998


7.		Phase II Study of Flavopiridol in Patients with Metastatic or Recurrent Colorectal Cancer (Summary Last Modified 01/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				JHOC-96110811 NCI-T96-0101, T96-0101

Last Modified: 4/1/2002 First Published: 4/1/1998


8.		Phase II Study of Flavopiridol in Patients With Previously Untreated Stage IV Non-Small Cell Lung Cancer (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				DFCI-97128 NCI-T97-0057, T97-0057

Last Modified: 5/9/2006 First Published: 5/1/1998


9.		Phase II Study of Flavopiridol in Patients with Metastatic Androgen Independent Adenocarcinoma of the Prostate (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				Not specified				NCI				WCCC-CO-9781 NCI-T97-0038, NCT00003256, T97-0038

Last Modified: 9/26/2006 First Published: 12/1/1998


10.		Phase II Study of Flavopiridol in Patients with Fludarabine Refractory B-Cell Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CLB-19805 NCT00003620, CALGB-19805

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute